Last reviewed · How we verify

NCT07424625

THAM VErsus Sodium BiCarbOnate In CaRdiac SuRgical PatiEnts, A PragmatiC, Comparative-effectiveness Prospective Trial

Not yet recruiting Phase 4 Last updated 22 April 2026
What this trial tests

Phase 4 trial testing Sodium bicarbonate in Metabolic Acidosis in 250 participants. Not yet recruiting.

Timeline
1 May 2026
Primary endpoint
1 February 2027
1 August 2027

Quick facts

Lead sponsorMayo Clinic
PhasePhase 4
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment250
Start date1 May 2026
Primary completion1 February 2027
Estimated completion1 August 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

21 and older, any sex, with Metabolic Acidosis. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The purpose of this research is to determine if two commonly used medications to treat metabolic acidosis in the setting of cardiac surgery, sodium bicarbonate and THAM, are equivalent.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sodium bicarbonate

Trials testing the same drug.

Other recruiting trials for Metabolic Acidosis

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07424625.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing